CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

NCT00277238 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis, Chronic Active

Interventions

DRUG: CPG10101
DRUG: CPG10101
DRUG: Control
DRUG: CPG10101

Sponsor

Pfizer